CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
about
Integrating electronic health record genotype and phenotype datasets to transform patient careThe impact of P2Y12 promoter DNA methylation on the recurrence of ischemic events in Chinese patients with ischemic cerebrovascular disease.Investigating Real-World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records.Benefit of pre-emptive pharmacogenetic information on clinical outcome.Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients.
P2860
CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@en
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@nl
type
label
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@en
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@nl
prefLabel
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@en
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@nl
P2093
P2860
P356
P1476
CYP2C19 and CES1 polymorphisms ...... anial atherosclerotic disease.
@en
P2093
Adrienne J Royster
Ben Burkley
Brian L Hoh
Caitrin W McDonough
Christian M Shaffer
Christie Ingram
Dan M Roden
James G Linneman
Julie A Johnson
P2860
P304
P356
10.3171/2015.6.JNS15795
P50
P577
2015-11-20T00:00:00Z